Search - tctmd.com

Displaying 161 - 180 of 193

Sort: Relevancy | Date

News Conference News TCT 2019

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Todd Neale

September 25, 2019

Presentation CHIP Seattle 2019

All Patients With Ami Cardiogenic Shock Should Receive Advanced Mechanical Circulatory Support

Presenter: William W. O’Neill

August 02, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

Presentation SIF 2019

My Favorite Mechanical Circulatory Support Case

Presenter: Manish A. Parikh

March 29, 2019

Presentation SIF 2019

MCS: Not Just a Tool for Complex PCI

Presenter: David G. Rizik

March 29, 2019

Presentation SIF 2019

Why Impella (Not IABP) is always the default choice in MCS

Presenter: Morton J. Kern

March 29, 2019

Presentation CIT 2019

Alternative Access in MCS and TAVR

Presenter: Duane Pinto

March 28, 2019

News Conference News ACC 2019

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Caitlin E. Cox

March 16, 2019

Presentation JIM 2019

Access Management with the Use of Mechanical Circulatory Support

Presenter: Nicolas M. Van Mieghem

February 14, 2019

Presentation TCT 2018

Case Presentation #3: STEMI With Cardiogenic Shock and No Simple Options for MCS

Presenter: Vladimir Dzavik, Richard Smalling, Ramesh K. Adiraju, Nicola Corvaja, Vasim Farooq, Sanjog Kalra, Barry D. Rutherford, Marco V. Wainstein

September 24, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles

November 06, 2017

Presentation Miami Valves 2017

Initiation of Acute MCS for HR-PCI

Presenter: John M. Lasala

January 29, 2017

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Daily News

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

Todd Neale

August 25, 2016

Presentation

Elective or Emergency Use of MechanicalCirculatory Support (MCS) Devices During TAVR

Presenter: Vikas Singh

August 25, 2016

News Daily News

高风险 PCI 的机械循环支持：设备、时间、术者和方式的指南

Todd Neale

May 05, 2016

News Daily News

Mechanical Circulatory Support in High-Risk PCI: A Guide to Which, When, Who, and How

Todd Neale

May 05, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

Advertisement

Strokes Increasing in STEMI Patients With Cardiogenic Shock

All Patients With Ami Cardiogenic Shock Should Receive Advanced Mechanical Circulatory Support

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

My Favorite Mechanical Circulatory Support Case

MCS: Not Just a Tool for Complex PCI

Why Impella (Not IABP) is always the default choice in MCS

Alternative Access in MCS and TAVR

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Access Management with the Use of Mechanical Circulatory Support

Case Presentation #3: STEMI With Cardiogenic Shock and No Simple Options for MCS

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Initiation of Acute MCS for HR-PCI

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

Elective or Emergency Use of MechanicalCirculatory Support (MCS) Devices During TAVR

高风险 PCI 的机械循环支持：设备、时间、术者和方式的指南

Mechanical Circulatory Support in High-Risk PCI: A Guide to Which, When, Who, and How

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content